Oral presentation 3rd prize

Prijs: Prize (including medals and awards)

Description

A phase I clinical trial on intratumoral administration of autologous CD1c(BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Datum van toekenning7 feb. 2020
Mate van erkenningNational

Toegekend op evenement

EvenementstitelBACR Annual Meeting 2020
LocatieVrije Universiteit Brussel, Campus Jette, Brussels, BelgiumToon op kaart
Periode7 feb. 2020 → 7 feb. 2020

    Vingerafdruk

Documenten & links